Introduction
Numerous observations suggest an involvement of the serotonin (5-hydroxytryptamine (5-HT)) system in the regulation of blood pressure levels; multiple studies have demonstrated increased vascular reactivity in response to serotonin in arteries from animals with different forms of hypertension. [1] [2] [3] [4] [5] [6] These findings prompted investigation of the effect of serotonin receptor ligands in both human and animal forms of hypertension. The results have been confusing with both agonists and antagonists having variable effects on blood pressure. 7, 8 5-HT 2A and 5-HT 2B receptor subtypes belong to the 5-HT 2 family of serotonin receptors and have been implicated in hypertension and other forms of cardiovascular disease such as pulmonary hypertension and atheroschlerosis due to their vasoconstrictive role 9 The 5-HT 2A receptor antagonist ketanserin has an antihypertensive action as the results of most but not all studies have suggested. 7, [10] [11] [12] [13] From these findings we hypothesised that hypertension may be a trait affected by polymorphic variation in the 5-HT 2A receptor gene. A common polymorphism in the 5-HT 2A receptor, the T102C silent mutation exhibits pleiotropic effects and has been associated with a variety of complex disease traits.
14-18 Here, we have conducted a genetic study to examine the role of the 5-HT 2A T102C polymorphism in hypertension. The T102C polymorphism does not result in an amino acid change but is in absolute linkage disequilibrium with the A-1438G polymorphism at the promoter region that may alter the levels of receptor expression.
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Subjects and methods
Subjects
The hypertensive group consisted of 342 survivors from 1083 subjects recruited into the cognitive substudy of the Medical Research Council (MRC) Hypertension Treatment Trial. The subjects were aged between 65 and 74 years when they entered the MRC trial in 1983/4 and were defined as hypertensive, while blood was collected 10 years later in 1994/5. The design of the MRC treatment trial study is described in detail elsewhere. 20 The control group consisted of a subset of 319 elderly people over 75 years, from the MRC Assessment of Elderly People in General Practice randomised to general practises throughout the UK that consisted in total of 1331 subjects. All 319 participants rested in a supine position for 5 min after which blood pressure recordings were done with a sphygmomanometer with the appropriate cuff size according to the recommendations of the British Hypertension Society. The average of two measurements for sitting diastolic and sitting systolic pressure was estimated. Duplicate measurements were performed once more at a subsequent time point and the average of all measurements was estimated. Normotensive individuals had a mean systolic and mean diastolic blood pressure index lower than 160 and 95 mm Hg. Inclusion criteria for hypertensive individuals were systolic blood pressure 160 to 209 mm Hg. Exclusion criteria were current antihypertensive medication and serious cardiovascular, cerebrovascular, or other intercurrent illnesses. The information on sex, age and body mass index was obtained.
Genotyping of T102C polymorphism
DNA was extracted from peripheral blood leukocytes using the Nucleon BACC2 kit (Biosciences) and following a standard procedure involving deproteinisation with sodium perchlorate and chloroform/NucleonResin extraction. Extracted DNA was stored at −70°C until assayed. The DNA was diluted to 25 ng/l and stored in 96-deep well plates at −20°C for their use in the experiments. Genotyping for the 5-HT 2A receptor gene polymorphism was carried out by PCR amplification followed by restriction enzyme digestion with Mspl, as previously described. 21 Amplification was conducted in a 25-volume containing 50-100 ng genomic DNA, 0.5 pmol each primer, 200 M dNTPs, 1.5-2 mM MgCl 2 , 0.05 U Taq polymerase in 1 × enzyme buffer consisting of 10 mM Tris-Cl (pH 8.3), 50 mM KCl, 0.001% w/v gelatin. After initial denaturation at 94°C for 5 min, 30 cycles of amplification were performed with denaturation at 94°C for 30 s, annealing for 30 s at the temperature optimised for each primer pair, extension at 72°C for 45 s, followed by a final extension at 72°C for 10 min. Visualisation of the bands was accomplished with silver stained polyacrylamide gels (10%).
Statistical analysis
Chi-square tests with Mantel-Haenszel correction were used to test for association with variation in the genotypic and allelic frequencies between hypertensive subjects and controls. The statistical package employed was EpiInfo (version 6). A confidence level of 95% was used in each test and P Ͻ 0.05 was considered statistically significant. The values for statistical power have been estimated with the aid of the computer package Epilnfo (version 6) and in each case a value of 95% has been used for the level of confidence. Table 1 summarises clinical characteristics of the subjects. Blood pressures were significantly higher in the hypertensive groups than in the normotensive subjects (P Ͻ 0.001). The case sample consisted of 120 male and 222 female hypertensive patients in the age range 76 to 88 years (in 1994/5). The control group consisted of age-matched individuals, from the MRC trial study of elderly in the UK community, 144 male and 175 female with average sitting systolic blood pressure below 160 mm Hg and diastolic below 95 mm Hg. The proportion of participants with the 102-C/102-C genotype was higher in the hypertensive group (35%) than in the normotensive group (27%) resulting in a significant difference ( 2 ϭ 7.09, P ϭ 0.03 (d.f. ϭ 2)) in the total population. Analysis by gender revealed that the effect was even more significant in the female group ( 2 ϭ 10.93, P ϭ 0.004 (d.f. ϭ 2)) but not significant in the male group. Similarly, allelic comparisons resulted in significant differences for the total group ( 2 ϭ 6.38, P ϭ 0.01 (d.f. ϭ 1), OR ϭ 1.33, 95% CI ϭ 1.06-1.66) and the female group ( 2 ϭ 9.70, P ϭ 0.002 (d.f. ϭ 1), OR ϭ 1.57, 95% CI ϭ 1.17-2.11). The results from chi-square sex-specific analysis of genotypes and alleles are summarised in Tables 2 and 3 , respectively. Genotyping was carried out blind to all clinical information and there was no deviation of the allelic frequencies from HardyWeinberg equilibrium in any group.
Results
Discussion
The identification of genes involved in the pathogenesis of essential hypertension has been the sub- ject of multiple genetic studies. Several gene associations have been reported including an intronic I/D polymorphism in the angiotensin converting enzyme (ACE), A1161 polymorphism of angiotensin II type I receptor gene, CYP11B2 gene polymorphism, and M325T angiotensinogen polymorphism. [22] [23] [24] [25] Furthermore, the ␤-2 adrenergic receptor has been implicated in the pathogenesis of hypertension due to the ␤-2 mediated vasodilatation and a significant association was identified between variants in the ␤-2 adrenergic receptor gene and hypertension. 26, 27 Finally, the T-58C promoter polymorphism of the ␤-2 bradykinin receptor gene was associated with essential hypertension in a Japanese population. 28 Replication studies however, have not verified these associations and the question as to which genes are pathogenetically involved in hypertension remains.
The neurotransmitter 5-hydroxytryptamine (5-HT, serotonin) has been implicated, since its discovery in 1948, 29 in a variety of cardiovascular diseases due to the increased serotonin-induced vascular reactivity in animal models of hypertension or atheroschlerosis. The 5-HT 2 family of receptors comprises 5-HT 2A , 5-HT 2B and 5-HT 2C receptor subtypes. The former two are expressed on the arteries, further suggesting a potential role in the regulation of blood pressure. 9 No molecular genetic association studies have yet tested the hypothesis that serotonin receptors may be involved in hypertension while most evidence comes mainly from pharmacological and molecular experiments. Most recently, however, a significant association was identified between a 5-
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HT 2C promoter polymorphism and type II diabetes 30 and this supports our suggestion for the involvement of the serotonergic system in the genetic aetiology of vascular disorders.
In the present study, we examined whether variation in the 5-HT 2A receptor gene influences blood pressure levels in an elderly population. Genotype analysis for the T102C 5-HT 2A polymorphism, which has previously been implicated in a variety of complex genetic disorders, [14] [15] [16] [17] [18] revealed a significant association with hypertension in the female group due to an excess of the 102-C/102-C genotype in the hypertensive participants. This suggests that the T102C 5-HT 2A polymorphism may be an independent risk factor for essential hypertension in females, conferring about a 60% increased risk (17-111%). A weakness in this study is that we did not have records of detailed ethnicity data for the control group and our results may be subject to population stratification. Nevertheless, we believe that the population has been of Caucasian origin and this is supported by the fact that the genotype distributions of our control group exactly matches the results from previous studies in control populations. 31 The nature of the T102C 5-HT 2A polymorphism does not help in our understanding of the biological consequence of the observed association because it is silent ie, it does not result in an amino acid change however it is in absolute linkage disequilibrium with the G-1438A polymorphism in the promoter region. 19 A functional role of the amino acid substitution in the promoter has not been identified,
but it has been suggested that there is an effect in the transcriptional regulation of the 5-HT 2A receptor gene possibly due to interaction between polymorphisms in the coding and promoter region. Furthermore, there may be other unidentified sequence variations at different positions in the promoter that are important. This latter explanation is supported by the fact that the basal promoter activity which comprises positions −25 to +1 is influenced by the upstream sequence −1314 to −75 whereas the sequence upstream the −1314 position does not influence promoter activity. 31 If this is the case then increased vasoconstriction that is apparent in hypertension may arise due to differential sensitivity to serotonin that is in turn determined by the density of serotonergic receptors. However, we acknowledge that such functional significance of the studied polymorphism in hypertension is completely speculative. Recent evidence suggests that the 5-HT 2A receptor is subject to polymorphic genomic imprinting that is the selective expression of one paternal allele (the maternal allele for the 5-HT 2A receptor). 32 Therefore, it may be that epigenetic influences rather than the mutation itself may play a role in the aetiopathogenesis of hypertension and can provide an alternative explanation to the observed association.
Our results revealed an association that was specific for the female group. This contradicts the fact that essential hypertension is more frequent among men although the reason for the sex-differences in the prevalence of the disease has not been established and could be attributable to environmental and social factors or even other unidentified genetic risk factors involved. Sexual dimorphism of the serotonergic system has been examined due to the increased occurrence of depression and other affective disorders in women. 33, 34 Differences between the sexes have been reported for the amount of serotonin release, the number of serotonergic neurons as well as for varied serotonin-mediated functions. This may be attributed to modulation of receptor expression by sex hormones. Alternatively, the gender-specificity of the association may be a result of the epigenetic status of 5-HT 2A such as unknown sex-specific interactions due to polymorphic imprinting described above.
In the present study we have provided genetic evidence that the 5-HT 2A receptor has a role in blood pressure regulation. This role may be mediated through peripheral vasoconstriction in synergism with serotonergic sympathomimetic effects. The genetic association is specific for the female group, which is in agreement with previous demonstrations for the differential expression and functionality of the 5-HT 2A receptor between the two sexes. Nevertheless, it is early to conclude with confidence that the 5-HT 2A gene is pathogenetically involved in hypertension and the requirement of replication studies in different populations as well as a more extensive SNP research and combined haplotype analysis may prove valuable.
